TAAR1 and psychiatric disorder: It is intriguing to speculate that these effects may also occur in response to upregulation of TAAR1 resulting from amphetamine-like psychostimulant abuse, imbalances in TAAR1 ligand availability due to neurotransmitter level dysregulation as in psychiatric diseases, or modulations to endogenous TA levels through diet or host-microbiome interactions.